• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Show Coverage: Affordability still the sticking point

Article

The industry is in an affordability crisis, according to Dan Spirek, executive vice president, chief strategy and marketing officer for TriZetto. He was a speaker during a Thursday presentation on managing post-reform healthcare. While he said that reform has increased access to care, he questioned its role in abating cost trends

The industry is in an affordability crisis, according to Dan Spirek, executive vice president, chief strategy and marketing officer for TriZetto. He was a speaker during a Thursday presentation on managing post–reform healthcare. While he said that reform has increased access to care, he questioned its role in abating cost trends.

Spirek proposed four imperatives to cope with a reformed marketplace:

Comply with reform. Payers need to adopt integrated enterprise systems to support administrative, care and network functions, while driving better coordination of benefits and delivery of care. If payers can efficiently implement benefit design changes, they can effectively comply with the mandates of reform and its future requirements.

Increase administrative efficiency. To meet medical loss ratio requirements, payers must reduce administrative overhead. To cope with “reform–related margin compression,” he recommends non–traditional strategies such as outsourcing business processes.

“Labor strategies [such as use of on-shore and mixed-shore models] have generally not been deployed beyond mailroom operations,” he said. “If we apply these initiatives to enrollment, billing, claims processing and benefit design, we can cut labor costs by as much as 50%.”

However, he emphasized the importance of using local resources for delivering customer–centered functions.

Improve cost and quality of care. The key is aligning incentives by rewarding value instead of volume through value–based strategies. Value based insurance design, which encourages higher value healthcare choices and sets barriers for lower value services, is an example of a consumer–driven strategy.

On the provider side, value–based reimbursement can help shift risk from payers to providers who are better positioned to manage risk, and influence the way providers deliver care. The potential to shift risk is represented by accountable care organizations, patient–centered medical homes and bundled payments.

Compete to win. Standing out from the crowd to effectively compete in a marketplace filled with new players can be achieved by leveraging technology. The results: attracting and retaining customer interest, increasing transactional efficiencies and engaging constituents.

Related Videos
Video 9 -"Overcoming Implementation Barriers for Digital Therapeutics Adoption"
Video 6 - "Failing to Reach Ideal Diabetes Care: Equitable Doesn’t Mean Equal"
Video 5 - "Revising Diabetes Outcome Measures"
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Related Content
© 2024 MJH Life Sciences

All rights reserved.